Recolony
1 known investors
Adularia (Recolony) develops cancer immunotherapies based on microbiome research, using a microbial metabolite mechanism that activates tumor-residing macrophages to trigger an anti-tumor immune response. The company designs an optimized, tumor-targeted immunotherapy molecule using multi-omics and AI-driven molecule design.</parameter> <parameter name="founders">[{"full_name": "Ana Montalban-Arques", "title": "CEO & Co-Founder"}, {"full_name": "Philipp Busenhart", "title": "COO & Co-Founder"}, {"full_name": "Egl\u0117 Katkevi\u010di\u016bt\u0117", "title": "CSO & Co-Founder"}, {"full_name": "David Seeberger", "title": "CFO"}]
AI & Machine LearningBiotechHealthtech
Investors Β· 1
Frequently asked questions
- What does Recolony do?
- Adularia (Recolony) develops cancer immunotherapies based on microbiome research, using a microbial metabolite mechanism that activates tumor-residing macrophages to trigger an anti-tumor immune response. The company designs an optimized, tumor-targeted immunotherapy molecule using multi-omics and AI-driven molecule design.</parameter> <parameter name="founders">[{"full_name": "Ana Montalban-Arques", "title": "CEO & Co-Founder"}, {"full_name": "Philipp Busenhart", "title": "COO & Co-Founder"}, {"full_name": "Egl\u0117 Katkevi\u010di\u016bt\u0117", "title": "CSO & Co-Founder"}, {"full_name": "David Seeberger", "title": "CFO"}]
- Who are Recolony's investors?
- Recolony's investors include Kickfund.